相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine
Marion Plaze et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2021)
Drug Repurposing to Identify Nilotinib as a Potential SARS-CoV-2 Main Protease Inhibitor: Insights from a Computational and In Vitro Study
Souvik Banerjee et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)
Unique Cytokine Response in West Nile Virus Patients Who Developed Chronic Kidney Disease: A Prospective Cohort Study
Michael Hansen et al.
VIRUSES-BASEL (2021)
The rise of West Nile Virus in Southern and Southeastern Europe: A spatial-temporal analysis investigating the combined effects of climate, land use and economic changes
J. Matthew Watts et al.
ONE HEALTH (2021)
Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors leflunomide and teriflunomide in Covid-19: A narrative review
Hardeep Kaur et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Discovery of re-purposed drugs that slow SARS-CoV-2 replication in human cells
Adam Pickard et al.
PLOS PATHOGENS (2021)
COVID-19 in teriflunomide-treated patients with multiple sclerosis
Amir Hadi Maghzi et al.
JOURNAL OF NEUROLOGY (2020)
Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2
Rui Xiong et al.
PROTEIN & CELL (2020)
Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library
Peilin Wang et al.
JOURNAL OF VIROLOGY (2018)
Screening of FDA-Approved Drugs for Inhibitors of Japanese Encephalitis Virus Infection
Shaobo Wang et al.
JOURNAL OF VIROLOGY (2017)
Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)-induced lymphoproliferative disease and lytic viral replication
Andrea Bilger et al.
ONCOTARGET (2017)
A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
Nicholas J. Barrows et al.
CELL HOST & MICROBE (2016)
Excretion of infectious Zika virus in urine
Fu-Chun Zhang et al.
LANCET INFECTIOUS DISEASES (2016)
A screen of the NIH Clinical Collection small molecule library identifies potential anti-coronavirus drugs
Jianzhong Cao et al.
ANTIVIRAL RESEARCH (2015)
A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity
Lisa M. Johansen et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
The Global Ecology and Epidemiology of West Nile Virus
Caren Chancey et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture
Adriaan H. de Wilde et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection
Julie Dyall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
Christian Confavreux et al.
LANCET NEUROLOGY (2014)
Nitazoxanide inhibits the replication of Japanese encephalitis virus in cultured cells and in a mouse model
Zixue Shi et al.
VIROLOGY JOURNAL (2014)
Identification of Three Antiviral Inhibitors against Japanese Encephalitis Virus from Library of Pharmacologically Active Compounds 1280
Jin'e Fang et al.
PLOS ONE (2013)
Antiviral or proviral action of mycophenolic acid in hepatitis B infection?
Qiuwei Pan et al.
HEPATOLOGY (2012)
Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
Paul O'Connor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Cilnidipine: A New Generation Ca2+ Channel Blocker with Inhibitory Action on Sympathetic Neurotransmitter Release
Akira Takahara
CARDIOVASCULAR THERAPEUTICS (2009)
Thiazolides, a New Class of Anti-influenza Molecules Targeting Viral Hemagglutinin at the Post-translational Level
Jean Francois Rossignol et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication
Brent E. Korba et al.
ANTIVIRAL RESEARCH (2008)
Inhibition of dengue virus replication by mycophenolic acid and ribavirin
Ratree Takhampunya et al.
JOURNAL OF GENERAL VIROLOGY (2006)
West Nile virus disease: A descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003
AV Bode et al.
CLINICAL INFECTIOUS DISEASES (2006)
Epidemiology and transmission dynamics of West Nile Virus disease
EB Hayes et al.
EMERGING INFECTIOUS DISEASES (2005)
West Nile Virus antibodies in Colombian horses
S Mattar et al.
EMERGING INFECTIOUS DISEASES (2005)
Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis C
M Cornberg et al.
JOURNAL OF HEPATOLOGY (2002)
分享论文
